Canadian biopharmaceutical company Aeterna Zentaris (Nasdaq: AEZS) has named Philip Theodore as senior vice president, chief administrative officer, general counsel and corporate secretary.
Mr Theodore was previously vice president, general counsel and corporate secretary of consumable chemical packaged goods company Zep Inc.
David Dodd, chairman and chief executive of Aeterna Zentaris, said: "We are very proud to welcome Philip to our leadership team, as he will be responsible for overseeing the day-to-day duties with respect to the administrative, legal, human resources, corporate development and corporate secretary functions. In developing his career, Philip has held increasingly responsible positions with several leading companies. He has extensive experience in merger and acquisition activities, integration of companies, management of numerous litigation matters as well as in counselling corporate management in regards to credit agreement negotiations, corporate disclosure issues and general contract issues. In his role, Phil will be an invaluable asset in establishing the platform for value growth and development of our company."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze